P90 Tandem versus single high dose chemotherapy (HDC)with haematopoietic stem cell support in patients with chemosensitive metastatic breast cancer (MBC): outcome parameters - results from a randomised multicenter phase III trial

Single versus tandem high dose chemotherapy (HDC) with hematopoietic stem cell support in patients with chemosensitive metastatic breast cancer (BC) –results from a multicenter phase III trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.6665 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 6665-6665 ◽

Cited By ~ 1

Author(s):

U. A. Nitz ◽

N. Kroeger ◽

M. Frick ◽

S. Mohrmann ◽

B. Metzner ◽

...

Keyword(s):

Metastatic Breast ◽

High Dose Chemotherapy ◽

Phase Iii ◽

High Dose ◽

Hematopoietic Stem ◽

Phase Iii Trial ◽

Stem Cell Support ◽

Multicenter Phase ◽

Single Versus ◽

Single versus tandem high dose chemotherapy (HDC) with hematopoietic stem cell support in patients with chemosensitive metastatic breast cancer (BC) –results from a multicenter phase III trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.6665 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 6665-6665

Author(s):

U. A. Nitz ◽

N. Kroeger ◽

M. Frick ◽

S. Mohrmann ◽

B. Metzner ◽

...

Keyword(s):

Metastatic Breast ◽

High Dose Chemotherapy ◽

Phase Iii ◽

High Dose ◽

Hematopoietic Stem ◽

Phase Iii Trial ◽

Stem Cell Support ◽

Multicenter Phase ◽

Single Versus ◽

The pharmacologic basis of high dose chemotherapy with haematopoietic stem cell support for solid tumours

British Journal of Cancer ◽

10.1054/bjoc.2001.1970 ◽

2001 ◽

Vol 85 (4) ◽

pp. 484-489 ◽

Cited By ~ 19

Author(s):

L F Porrata ◽

A A Adjei

Keyword(s):

Stem Cell ◽

High Dose Chemotherapy ◽

Solid Tumours ◽

Haematopoietic Stem Cell ◽

High Dose ◽

Stem Cell Support ◽

HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1704619 ◽

2004 ◽

Vol 34 (5) ◽

pp. 413-417 ◽

Cited By ~ 7

Author(s):

V Guarneri ◽

C Bengala ◽

C Orlandini ◽

A Gennari ◽

S Donati ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Her2 Overexpression ◽

Breast Cancer Patients ◽

Stem Cell Support ◽

Single-Agent Paclitaxel in Patients With Metastatic Breast Cancer Receiving High-Dose Chemotherapy With Peripheral Blood Stem Cell Support

American Journal of Clinical Oncology ◽

10.1097/00000421-199904000-00011 ◽

1999 ◽

Vol 22 (2) ◽

pp. 162-167

Author(s):

L. S. Schwartzberg ◽

C. H. Weaver ◽

R. Birch ◽

R. Giudice ◽

E. Sobong ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Peripheral Blood Stem Cell ◽

Single Agent ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Stem Cell Support ◽

Comparison of rapidly cycled tandem high-dose chemotherapy plus peripheral-blood stem-cell support versus dose-dense conventional chemotherapy for adjuvant treatment of high-risk breast cancer: results of a multicentre phase III trial

The Lancet ◽

10.1016/s0140-6736(05)67784-7 ◽

2005 ◽

Vol 366 (9501) ◽

pp. 1935-1944 ◽

Cited By ~ 87

Author(s):

Ulrike Anneliese Nitz ◽

Svjetlana Mohrmann ◽

Johannes Fischer ◽

Walter Lindemann ◽

Wolfgang E Berdel ◽

...

Keyword(s):

High Dose Chemotherapy ◽

Phase Iii ◽

High Dose ◽

Phase Iii Trial ◽

Multicentre Phase ◽

Dose Dense ◽

High Risk Breast Cancer ◽

High Risk Breast ◽

Cell Support ◽

Risk Breast Cancer

Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer: a phase II multicentre study

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1705302 ◽

2006 ◽

Vol 37 (7) ◽

pp. 651-659 ◽

Cited By ~ 4

Author(s):

A Gonçalves ◽

R Delva ◽

M Fabbro ◽

L Gladieff ◽

J-P Lotz ◽

...

Keyword(s):

Ovarian Cancer ◽

Stem Cell ◽

Advanced Ovarian Cancer ◽

High Dose Chemotherapy ◽

Haematopoietic Stem Cell ◽

High Dose ◽

Line Treatment ◽

Front Line ◽

Stem Cell Support ◽

A phase III randomised trial of sequential high dose chemotherapy (HDC) with peripheral blood stem cell support or standard dose Chemotherapy (SDC) for first-line treatment of ovarian cancer

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.5006 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 5006-5006 ◽

Cited By ~ 2

Author(s):

J. A. Ledermann ◽

N. Frickhofen ◽

H. Wandt ◽

C. Bengala ◽

K. Champion ◽

...

Keyword(s):

Peripheral Blood Stem Cell ◽

Standard Dose ◽

Randomised Trial ◽

High Dose Chemotherapy ◽

Phase Iii ◽

High Dose ◽

First Line ◽

Stem Cell Support ◽

Cell Support ◽

First Line Treatment

Use of Capecitabine as First-Line Therapy in Patients with Metastatic Breast Cancer Relapsing After High-Dose Chemotherapy and Autologous Stem Cell Support

Clinical Oncology ◽

10.1007/s001740170007 ◽

2001 ◽

Vol 13 (6) ◽

pp. 434-437

Author(s):

A. Bashey ◽

S. Sundaram ◽

S. Corringham ◽

V. Jones ◽

D. Lancaster ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

First Line ◽

Stem Cell Support ◽

First Line Therapy ◽

Line Therapy ◽

A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a single cycle

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1702172 ◽

2000 ◽

Vol 25 (5) ◽

pp. 519-524 ◽

Cited By ~ 6

Author(s):

A Bashey ◽

S Corringham ◽

J Garrett ◽

TA Lane ◽

EA Gilpin ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii Study ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Single Cycle ◽

Eligibility Criteria ◽

Stem Cell Support ◽